SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-000709
Filing Date
2023-01-06
Accepted
2023-01-06 06:03:28
Documents
12
Period of Report
2023-01-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39195
  Complete submission text file 0001493152-23-000709.txt   215794

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ghsi-20230105.xsd EX-101.SCH 3245
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ghsi-20230105_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ghsi-20230105_pre.xml EX-101.PRE 22371
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3728
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 23513676
SIC: 2834 Pharmaceutical Preparations